The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta‐analysis

By S. Roberge, K. Nicolaides, S. Demers, J. Hyett, N. Chaillet, E. Bujold. American Journal of Obstetrics and Gynecology, 2017

613 citations recorded by the source corpus.

Subfields: Obstetrics and Gynecology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/ae428e166d6806edac9bac14b998c5f66cdc589f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Public Health, Environmental and Occupational Health

1. Hyagriv Simhan

Citations in the corpus

• The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice. (2018, background): “Recent analyses question: a) whether aspirin needs be started before 16 weeks or still has benefit if started later, b) the magnitude of effect (ranging from 50% to only 10% risk reduction) and c) what dose is most beneficial, at least 100 mg seeming to be required(67-69).”
• Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222. (2020, background): “was started before 16 weeks of gestation (100).”